# Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients

> **NCT03143751** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 370 (actual)

## Conditions studied

- Moderate to Severe Traumatic Brain Injury

## Interventions

- **DRUG:** NaCl20% (Continuous hyperosmolar therapy)

## Key facts

- **NCT ID:** NCT03143751
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-31
- **Primary completion:** 2020-03-05
- **Final completion:** 2020-03-05
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03143751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03143751, "Continuous Hyperosomolar Therapy for Traumatic Brain-injured Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03143751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*